Pediatric Radiology Department, AP-HP, Hôpital Universitaire Necker-Enfants Malades, 75015, Paris, France.
INSERM U1299, Université Paris Cité, 75015, Paris, France.
Clin Neuroradiol. 2024 Dec;34(4):939-950. doi: 10.1007/s00062-024-01444-w. Epub 2024 Aug 2.
Supratentorial (ST) ependymoma subgroups are defined by two different fusions with different prognoses. Astroblastomas, MN1-altered, have ependymal-like histopathologic features and represent a differential diagnosis in children. We hypothesized that ZFTA-fused ependymoma and YAP1-fused ependymoma on the one hand, and astroblastoma, MN1-altered, on the other hand, show different MRI characteristics.
We retrospectively analyzed the preoperative imaging of 45 patients with ST ependymoma or astroblastoma between January 2000 and September 2020, blinded to histomolecular grouping. Several characteristics, such as location, tumor volume, calcifications, solid/cystic component, and signal enhancement or diffusion were evaluated. We compared imaging characteristics according to their molecular subtype (ZFTA-fused, YAP1-fused, and astroblastoma, MN1-altered).
Thirty-nine patients were classified as having an ependymoma, 35 with a ZFTA fusion and four with a YAP1 fusion, and six as having an astroblastoma, MN1-altered. YAP1-fused ependymomas were more likely to involve at least 3 lobes than ZFTA-fused ependymomas. Astroblastomas were located in the frontal lobe in 100% of the tumors versus 49% of the ependymomas. Cerebral blood flow by arterial spin labeling was higher in astroblastomas than in ependymomas. There were no differences in the other characteristics between the molecular groups. All the tumors showed common features: intra-axial extra-ventricular tumors, very frequent contrast enhancement (39/43, 91%), a cystic/necrotic component (41/45, 91%), restricted diffusion (32/36, 89%), calcifications (15/18, 83%), and peri-tumoral edema (38/44, 86%).
The distinction between ST ependymoma subtypes and astroblastomas can be guided by several imaging features. These tumors share common imaging features that may help to differentiate ST ependymomas and astroblastomas from other pediatric ST tumors.
幕上(ST)室管膜瘤亚组由两种不同融合的预后不同的肿瘤定义。星形母细胞瘤、MN1 改变型,具有室管膜样组织病理学特征,是儿童的鉴别诊断。我们假设一方面 ZFTA 融合型室管膜瘤和 YAP1 融合型室管膜瘤,另一方面星形母细胞瘤、MN1 改变型,显示出不同的 MRI 特征。
我们回顾性分析了 2000 年 1 月至 2020 年 9 月间 45 例 ST 室管膜瘤或星形母细胞瘤患者的术前影像学资料,对组织分子分组情况进行了盲法评估。评估了肿瘤的位置、肿瘤体积、钙化、实性/囊性成分、信号增强或弥散等多个特征。根据分子亚型(ZFTA 融合型、YAP1 融合型和星形母细胞瘤、MN1 改变型)比较了影像学特征。
39 例患者被分类为室管膜瘤,35 例为 ZFTA 融合型,4 例为 YAP1 融合型,6 例为星形母细胞瘤、MN1 改变型。与 ZFTA 融合型室管膜瘤相比,YAP1 融合型室管膜瘤更有可能累及至少 3 个脑叶。星形母细胞瘤在所有肿瘤中均位于额叶,而室管膜瘤中仅占 49%。动脉自旋标记脑血流在星形母细胞瘤中高于室管膜瘤。在其他特征方面,分子组之间没有差异。所有肿瘤均表现出共同特征:脑室内肿瘤,非常常见的对比增强(39/43,91%),囊性/坏死成分(41/45,91%),弥散受限(32/36,89%),钙化(15/18,83%)和瘤周水肿(38/44,86%)。
ST 室管膜瘤亚型和星形母细胞瘤的鉴别可通过几种影像学特征来指导。这些肿瘤具有共同的影像学特征,有助于将 ST 室管膜瘤和星形母细胞瘤与其他小儿 ST 肿瘤区分开来。